Patients with PD were distributed into two subgroups: the leucine-rich repeat kinase 2 (LRRK2) mutation PD (LRRK2+) and the LRRK2 mutation-free (LRRK2−) PD groups. The gene discussed is LRRK2; the disease is Parkinson disease.